Patents Assigned to VERAMARX, INC.
  • Biomarker signatures for lyme disease differentiation and methods of use thereof
    Patent number: 10725038
    Abstract: The present invention relates to methods for the differentiating, diagnosing, and treating Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature capable of differentiating Lyme disease from like-symptom diseases, the biomarker signature being comprised of a combination of two or more analytes.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: July 28, 2020
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Biomarker signatures for Lyme disease and methods of use thereof
    Patent number: 10725039
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: July 28, 2020
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Biomarker signatures for lyme disease and methods of use thereof
    Patent number: 10274491
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: April 30, 2019
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • BIOMARKER SIGNATURES FOR LYME DISEASE AND METHODS OF USE THEREOF
    Publication number: 20170336409
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Application
    Filed: July 7, 2015
    Publication date: November 23, 2017
    Applicant: VERAMARX, INC.
    Inventors: Whitney RICHARDS, Floyd E. TAUB, Robert A. RUBIN